Yongin Severance Hospital
Yongin-si, Gyeonggi-do, 16995, South Korea
Location status: Recruiting
Location contact
Na Young Kim, MD, PhD
CONTACT
Na Young Kim, MD, PhD
PRINCIPAL_INVESTIGATOR
Seung Ick Choi
CONTACT
NCT Number: NCT07716475
The goal of this clinical trial is to learn whether a wearable monitoring system can help adults who have had a stroke get more out of a home exercise program. The system tracks how participants walk and move, then gives them feedback. Researchers want to know if this feedback improves walking, thinking and memory, and daily activity.
The wearable monitoring system has three parts:
A shoe insole sensor that measures how a person walks A wrist band that tracks daily activity, like a fitness watch A mobile app that gives feedback and lets participants report how they feel
The main questions this study aims to answer are:
Does feedback from the wearable system improve physical function, thinking and memory, and daily activity during a home exercise program? How satisfied are participants with using the wearable system?
Researchers will compare two groups. Both groups do the same home exercise program for 6 weeks. One group uses the wearable system and gets feedback. The other group does the program without the wearable system or feedback. This comparison shows whether the feedback itself makes a difference.
Who can take part: adults who have had a stroke and [key eligibility in plain words, e.g., "can walk a short distance with or without help"]. The study plans to enroll about [number] participants.
Participants in the wearable group will:
Get an insole sensor, a wrist activity tracker, and access to a mobile app Learn a home exercise program from the study team Wear the insole sensor and activity tracker while exercising at home for 6 weeks Use the app to see their feedback and report daily health information Complete a survey about their experience at the end
Participants in the comparison group will:
Do the same home exercise program for 6 weeks, without the wearable system or feedback.
Interested in participating?
Request Info19 year–80 year
All sexes
Interventional
Not applicable
Yongin-si, Gyeonggi-do, 16995, South Korea
Location status: Recruiting
Na Young Kim, MD, PhD
CONTACT
Na Young Kim, MD, PhD
PRINCIPAL_INVESTIGATOR
Seung Ick Choi
CONTACT
After obtaining written consent, a screening test is performed. In the screening test, after taking a history of the subject's baseline symptoms and signs, the past history and medication history are confirmed, vital signs are measured, and a physical examination is conducted, and the overall gait status such as whether assistive devices are used during gait and the gait pattern is assessed. Subjects who pass the screening test undergo the initial assessment within 7 days.
The initial assessment is conducted including the 2-Minute Walk Test, spatiotemporal gait parameters, the Berg Balance Scale, and subjects who complete the initial assessment begin robot-assisted gait training on the same day.
After the initial assessment, gait training using the hip-assisted wearable robot is performed in the home or an indoor space near the home twice a week for 2 weeks, a total of 4 times, for 30 minutes each. The interval between each intervention visit is set not to exceed 5 days.
After the end of the 2 weeks of robot-assisted gait training, on the day of completion, the end-of-study assessment is performed identically to the initial assessment, and a satisfaction assessment for the hip-assisted wearable robot is conducted.
In addition, when a device abnormality occurs, measures are taken and the relevant details are recorded, the usability of the hip-assisted wearable robot is analyzed, the gait and balance function assessment results in the non-wearing/wearing states of the hip-assisted wearable robot are statistically compared before and after gait training, and the burden and satisfaction assessments of the hip-assisted wearable robot are analyzed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A hip-assisted wearable robot (wearable gait-assist robot) that assists flexion and extension of the hip joint during walking. The battery-powered device is controlled through a paired mobile application via Bluetooth, and its assistive force can be adjusted to each participant. A visiting physical or occupational therapist applies the device and delivers gait training at the participant's home for 4 sessions over 2 weeks, 30 minutes per session, under a physician's prescription and supervision.
Time frame: At the end of the 2-week intervention (after session 4)
Usability of the home-based robot-assisted gait rehabilitation service, measured with a questionnaire based on the Telehealth Usability Questionnaire (TUQ). Items are rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree); higher scores indicate better usability. Total and item scores are summarized.
Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
Patients are instructed to walk back as many times as possible within 2 minutes. The examiner records the total distance covered, abnormal gait patterns, and the time of occurrence of any gait deviations.
Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Cadence: The number of steps taken per minute, measured in steps per minute (spm).
Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Total Step Count: The total number of steps taken during walking.
Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Self-Selected Walking Speed: The participant's walking speed when walking naturally at a comfortable pace.
Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Distance: The total distance covered during walking, measured in meters (m).
Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
While the participant performs the test wearing an insole-type gait analyzer, spatiotemporal gait parameters are collected and recorded. Stride Length: The distance between the heel of one foot to the heel of the same foot during consecutive steps. Measured in meters (m), stride length is adjusted for height to account for differences in body size.
Time frame: Baseline (Day 1) and end of the 2-week intervention (Week 2, after session 4)
Patients are asked to perform 14 tasks regarding the static and dynamic balance of patients. Each task was rated on a five-point scale from 0 to 4, with a total score of 56.
Time frame: At the end of the 2-week intervention (after session 4)
Satisfaction with the device and home-based service, measured with the 12-item, 5-point Korean version of the Quebec User Evaluation of Satisfaction with Assistive Technology (K-QUEST 2.0). Each item is scored from 1 to 5, and the total score is the sum of the 12 items, ranging from a minimum of 12 to a maximum of 60. Higher scores indicate greater satisfaction.
Contact information is provided by the study sponsor or research team.
Na Young Kim, MD, PhD
CONTACT
Seung Ick Choi
CONTACT
Yonsei University
Other
A Study to Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke Patients: An Investigator-Initiated, Single-Center, Single-Arm Exploratory Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05378035
Arrhythmias, Cardiac, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT03821129
Brain Diseases, Cardiovascular Abnormalities
Tucson, Arizona, United States
View Trial DetailsNCT06615973
Brain Disease, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07737431
Brain Diseases, Cardiovascular Diseases
Hung Hom, Kowloon, Hong Kong
View Trial Details